Trials / Not Yet Recruiting
Not Yet RecruitingNCT06289686
MIRROR Project 44 - Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Brooke Army Medical Center · Federal
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Rotator cuff (RC) injuries are particularly prevalent, difficult to repair, and attachment between the bone and tendon is notoriously difficult to achieve. The most common method and current standard of care (SOC) for reattaching connective tissues (e.g., ligaments, tendons) to bone typically involves suture anchor-based techniques, but this is fraught with problems. More specifically, re-tearing of the connective tissue after this procedure occurs in 30-60% of cases, and can be even higher in patients who engage in smoking, have a diagnosis of diabetes, etc. To address these clinical challenges, Sparta Biopharma Inc. (Sparta) developed a unique technology, called BioEnthesis, to improve the connection between the tendon and bone. Pre-clinical in vivo studies demonstrated that the biphasic bovine cancellous matrix regenerated at the bone-soft tissue interface-thereby leading to high structural integrity and will likely lead to reduced re-tear rates over time. The investigators hypothesize that patients in this interventional cohort will experience enhanced mobility, reduced pain, and less re-tears after RC procedures versus a standard suture anchor-based repair.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Rotator cuff repairs with BioEnthesis augmentation | Rotator cuff repair using BioEnthesis allograft patch |
| PROCEDURE | Rotator cuff repairs without BioEnthesis augmentation | Rotator cuff repair using standard of care sutures and anchors |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2024-03-04
- Last updated
- 2024-06-07
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06289686. Inclusion in this directory is not an endorsement.